(Q36684197)

15 August 2017

1 reference

title

Modifying the anti-inflammatory effects of high-density lipoprotein (English)

1 reference

15 August 2017

1 reference

2

Gregg C Fonarow

1 reference

15 August 2017

Benjamin J Ansell

1

1 reference

PubMed ID

17169248

15 August 2017

Mohamad Navab

series ordinal

3

1 reference

PubMed ID

17169248

15 August 2017

Alan M Fogelman

series ordinal

4

1 reference

15 August 2017

1 January 2007

1 reference

Current Atherosclerosis Reports

15 August 2017

1 reference

15 August 2017

9

1 reference

15 August 2017

1

1 reference

15 August 2017

57-63

1 reference

https://scigraph.springernature.com/pub.10.1007/bf02693941

15 August 2017

0 references

cites work

High-density lipoprotein loses its anti-inflammatory properties during acute influenza a infection

1 reference

https://api.crossref.org/works/10.1007%2FBF02693941

The double jeopardy of HDL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02693941

Decreased protection by HDL from poorly controlled type 2 diabetic subjects against LDL oxidation may Be due to the abnormal composition of HDL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02693941

Localization of nitration and chlorination sites on apolipoprotein A-I catalyzed by myeloperoxidase in human atheroma and associated oxidative impairment in ABCA1-dependent cholesterol efflux from macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02693941

Reverse cholesterol transport in man: promotion of fecal steroid excretion by infusion of reconstituted HDL.

21 January 2018

1 reference

12 December 2020

Oxidized lipoproteins including HDL and their lipid peroxidation products inhibit TNF-alpha secretion by THP-1 human macrophages

1 reference

12 December 2020

Regulation of reverse cholesterol transport and clinical implications

1 reference

12 December 2020

Consumption of saturated fat impairs the anti-inflammatory properties of high-density lipoproteins and endothelial function.

1 reference

12 December 2020

PON1 paraoxonase activity is reduced during HDL oxidation and is an indicator of HDL antioxidant capacity

1 reference

12 December 2020

Defective antioxidative activity of small dense HDL3 particles in type 2 diabetes: relationship to elevated oxidative stress and hyperglycaemia.

1 reference

12 December 2020

High-density lipoproteins reduce the intestinal damage associated with ischemia/reperfusion and colitis

1 reference

12 December 2020

Statins downregulate myeloperoxidase gene expression in macrophages

1 reference

12 December 2020

Structural modifications of HDL and functional consequences

1 reference

12 December 2020

Endothelial and antithrombotic actions of HDL.

1 reference

12 December 2020

The inflammation: lipoprotein cycle

1 reference

12 December 2020

High-density lipoprotein function recent advances

1 reference

12 December 2020

Glycation impairs high-density lipoprotein function

1 reference

12 December 2020

A new antiinflammatory compound, leumedin, inhibits modification of low density lipoprotein and the resulting monocyte transmigration into the subendothelial space of cocultures of human aortic wall cells

1 reference

12 December 2020

D-4F and statins synergize to render HDL antiinflammatory in mice and monkeys and cause lesion regression in old apolipoprotein E-null mice

1 reference

12 December 2020

Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease

1 reference

12 December 2020

Reconstituted high-density lipoprotein attenuates organ injury and adhesion molecule expression in a rodent model of endotoxic shock

1 reference

12 December 2020

Inflammatory/antiinflammatory properties of high-density lipoprotein distinguish patients from control subjects better than high-density lipoprotein cholesterol levels and are favorably affected by simvastatin treatment

1 reference

12 December 2020

Enhanced cholesterol efflux by tyrosyl radical-oxidized high density lipoprotein is mediated by apolipoprotein AI-AII heterodimers

1 reference

12 December 2020

High-density lipoprotein hydrolysis by endothelial lipase activates PPARalpha: a candidate mechanism for high-density lipoprotein-mediated repression of leukocyte adhesion.

1 reference

12 December 2020

Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study.

1 reference

12 December 2020

Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR* Trial).

1 reference

12 December 2020

Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial

1 reference

12 December 2020

Oral administration of an Apo A-I mimetic Peptide synthesized from D-amino acids dramatically reduces atherosclerosis in mice independent of plasma cholesterol

1 reference

12 December 2020

High-density lipoprotein: is it always atheroprotective?

1 reference

12 December 2020

Regression of atherosclerotic lesions by high density lipoprotein plasma fraction in the cholesterol-fed rabbit

1 reference

12 December 2020

High-Density Lipoproteins Inhibit Cytokine-Induced Expression of Endothelial Cell Adhesion Molecules

1 reference

12 December 2020

Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host

1 reference

12 December 2020

Apolipoprotein A-I mimetic peptides and their role in atherosclerosis prevention

1 reference

12 December 2020

A longitudinal analysis of alteration in lecithin-cholesterol acyltransferase and paraoxonase activities following laparoscopic cholecystectomy relative to other parameters of HDL function and the acute phase response.

1 reference

12 December 2020

Regulation of serum paraoxonase activity by genetic, nutritional, and lifestyle factors in the general population.

1 reference

12 December 2020

Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: step 1.

1 reference

12 December 2020

Proinflammatory high-density lipoprotein as a biomarker for atherosclerosis in patients with systemic lupus erythematosus and rheumatoid arthritis

1 reference

12 December 2020

Administration of tyrosyl radical-oxidized HDL inhibits the development of atherosclerosis in apolipoprotein E-deficient mice

1 reference

12 December 2020

HDL and arteriosclerosis: beyond reverse cholesterol transport

1 reference

12 December 2020

Simvastatin decreases aldehyde production derived from lipoprotein oxidation

1 reference

12 December 2020

Effect of glycation of high density lipoproteins on their physicochemical properties and on paraoxonase activity

1 reference

12 December 2020

Acute-phase proteins and other systemic responses to inflammation

1 reference

12 December 2020

Oral D-4F causes formation of pre-beta high-density lipoprotein and improves high-density lipoprotein-mediated cholesterol efflux and reverse cholesterol transport from macrophages in apolipoprotein E-null mice

1 reference

12 December 2020

Protective effects of high-density lipoprotein against oxidative stress are impaired in haemodialysis patients

1 reference

12 December 2020

Oral small peptides render HDL antiinflammatory in mice and monkeys and reduce atherosclerosis in ApoE null mice.

1 reference

12 December 2020

Serum opacity factor, a streptococcal virulence factor that binds to apolipoproteins A-I and A-II and disrupts high density lipoprotein structure.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02693941

1 reference

15 August 2017

1 reference

PubMed ID

17169248